Engineering a safe monoclonal anti‐human IL‐2 that is effective in a murine model of food allergy and asthma-Reference-Cited by-同舟云学术

Engineering a safe monoclonal anti‐human IL‐2 that is effective in a murine model of food allergy and asthma

Published:2021-08-07 Issue: Volume: Page:
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Klein Martin¹,Misme‐Aucouturier Barbara²,Cheminant Marie‐Aude¹,De Carvalho Marion²,Wauters Marie³,Tranquet Olivier²,Magnan Antoine⁴,Bouchaud Grégory²^ORCID

Affiliation:

1. Université de Nantes, CNRS, INSERM, l’institut du thorax Nantes France

2. Biopolymères Intéractions Assemblages (BIA) INRAE Nantes France

3. GZA Hospital & Health Care Antwerpen Belgium

4. Université de Nantes, CHU Nantes, CNRS, INSERM, l’institut du thorax Nantes France

Funder

Fonds de Recherche en Santé Respiratoire

Fondation du Souffle

Agence Nationale de la Recherche

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.15029

Reference57 articles.

1. Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2

2. IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor α subunit CD25

3. Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells

4. IL-3 Induces Basophil Expansion In Vivo by Directing Granulocyte-Monocyte Progenitors to Differentiate into Basophil Lineage-Restricted Progenitors in the Bone Marrow and by Increasing the Number of Basophil/Mast Cell Progenitors in the Spleen

5. IL-7/Anti-IL-7 mAb Complexes Restore T Cell Development and Induce Homeostatic T Cell Expansion without Lymphopenia

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision medicine for asthma treatment: Unlocking the potential of the epigenome and microbiome;Journal of Allergy and Clinical Immunology;2024-06

2. A CD25-biased interleukin-2 for autoimmune therapy engineered via a semi-synthetic organism;Communications Medicine;2024-03-26

3. Immunoswitch Nanomodulators Enable Active Targeting and Selective Proliferation of Regulatory T Cells for Multiple Sclerosis Therapy;ACS Nano;2023-12-19

4. The T-Cell Growth Factor Interleukin-2, Which Is Occasionally Targeted by Autoantibodies, Qualifies as Drug for the Treatment of Allergy, Autoimmunity, and Cancer: Collegium Internationale Allergologicum (CIA) Update 2024;International Archives of Allergy and Immunology;2023-12-12

5. The IL-2A receptor pathway and its role in lymphocyte differentiation and function;Cytokine & Growth Factor Reviews;2022-10